A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Incyte Corporation
Incyte Corporation
Janssen Research & Development, LLC
Hoffmann-La Roche
Tizona Therapeutics, Inc
Novartis
Incyte Corporation
Debiopharm International SA
Sapience Therapeutics
IGM Biosciences, Inc.
Boehringer Ingelheim
Biosplice Therapeutics, Inc.
AbbVie
AbbVie
Mereo BioPharma
Mereo BioPharma
Bionomics Limited
AbbVie
AbbVie
Daiichi Sankyo
EMD Serono
Amgen